Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...
Texas football offseason news: Transfer portal, roster updates, recruiting outlook from Longhorns experts
The Horns247 team has its finger on the pulse of Texas transfer portal news, recruiting, coaching staff moves and more as ...
Can you spot it? 15 corporate logos with hidden meanings
Stretch the numbers and you have the charitable womenswear's logo name in one element. There are classics, and then, there is ...
Delta's Holiday Travel Surge Fuels Record Revenue in Q4
The airline exceeded profit and revenue expectations thanks to a surge in holiday travel and lower fuel costs.
HTX 2025 Outlook: Five Sectors to Look Forward to, and How Trump's Policy Will Affect Crypto Industry
The year 2024 marks a significant chapter in the history of the crypto industry, where we witnessed continuous breakthroughs ...
Hosted on MSN3d
Arnold Palmer umbrella logo: How it was created, what it means
The Arnold Palmer umbrella logo is unmistakable, and we've seen it all over the places and people Mr. Palmer touched in the ...
Younger millennials and older Gen Zers were wise to not buy homes last year — but 2025 may be much different
Millennials and Gen Zers made the right call by not buying homes last year as mortgage rates wreaked havoc. Here's what's set ...
Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral ...